Oral Therapy and Adherence in Lymphoma

An increasing number of lymphoma and chronic lymphocytic leukemia (CLL) patients receive their chemotherapy not from intravenous (IV) treatments administered in a hospital or clinic, but via a pill, taken at home on a regular basis. These oral therapies have become a more standard part of patient care, and for a growing number of patients, oral therapies are their only option. Living with Lymphoma hosts, Victor Gonzalez and Izumi Nakano, sat down with LRF Lymphoma Scientific Research Mentoring Program grantee, Craig Portell, MD (University of Virginia) who explained oral therapies and its use for the treatment of certain types of lymphoma. They were joined by chronic lymphocytic leukemia (CLL) survivor, Geoff Grubbs, who discussed his experience with oral therapies and how this treatment regimen has been beneficial to him throughout his journey.

Helpful Resources:

• LRF Helpline (800-500-9976; helpline@lymphoma.org)
• Oral Therapy Learning Center
• Oral Agents in Lymphoma Fact Sheet
• Oral Anticancer Adherence in Lymphoma Fact Sheet
• Craig Portell, MD Researcher Spotlight
• Geoff Story of Hope